Epidiolex, the only plant-derived cannabis drug approved by the U.S. Food and Drug Administration, is no longer considered a controlled substance, providing a boost to its manufacturer’s stock price. GW Pharmaceuticals, a biopharmaceutical company based in London, saw its stock go up 5.9% on Tuesday, one day after the U.S. Drug Enforcement Administration said it […]Read More
Australis Capital, a cannabis investment firm based in Las Vegas, terminated its planned acquisition of hemp company Folium Biosciences in the wake of lurid headlines that surfaced regarding the Colorado company it was going to purchase only two months ago. Australis, a spin-off of Canadian marijuana producer Aurora Cannabis, said in a news release it […]Read More
Cannalysis, a hemp and cannabis testing lab based in California, raised $22.6 million that it said will fund its expansion in the state as well as helping it to move into other marijuana markets in the U.S. The Santa Ana-based company raised the money from Canlab, a cannabis, hemp and CBD testing laboratory network. The […]Read More
- August 6, 2020August 5, 2020August 3, 2020
- August 3, 2020July 30, 2020July 29, 2020
- July 28, 2020July 27, 2020
Get ready for our 2020 events:
- MJBizCon Vegas
December 2-4, 2020
COMING SOON! »
Kristen Nichols Interviews Angela Dawson, CEO of Forty Acre CooperativeHemp Industry Daily editor, Kristen Nichols, Interviews Angela Dawson, founder and CEO of Forty Acre Cooperative.
CBD liver study to inform FDA regulation gains support for deployment next monthHemp Industry Daily reporter, Laura Drotleff, interviews industry experts about a CBD liver study set to deployment next month
Hemp Week ReimaginedHemp Industry Daily editor, Kristen Nichols, interviews Rick Trojan, president of the Hemp Industries Association, in honor of Hemp Week!